Gen House

Suzhou, China · Founded 2014 · In IPO Registration

Developer of original anti-tumor drugs designed for anti-cancer therapeutics. Gen House is based in Suzhou, China and was founded in 2014. Its last reported valuation was $268 million in Jan 2026. It has raised $121 million.

Last reported valuation

$268.3M

Oct 2026

Priced at

—

Total raised

$120.5M

Last round

—

How much has Gen House raised?

$120.5Macross 0 recorded rounds

Free account

More of Gen House with a free account

·The complete investor list: 23 names
·Watch Gen House: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Gen House investors

23 investors are on record for Gen House, including Shenzhen Capital Group, Green Pine Capital Partners, Legend Star and YuanBio Venture Capital. By type, the record holds 4 venture capital firms and 1 hedge fund.

For fundraisers

Raising for a company like Gen House?

23 investors have backed Gen House.

See all 23 investors →

Frequently asked about Gen House

How much has Gen House raised?: Gen House has raised $120.5M in total across 0 recorded funding rounds.